Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$436M |
| 2 |
United Therapeutics
UTHR
|
+$393M |
| 3 |
Amazon
AMZN
|
+$376M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$372M |
| 5 |
Visa
V
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$313M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$272M |
| 3 |
Stellantis
STLA
|
+$222M |
| 4 |
TSMC
TSM
|
+$215M |
| 5 |
Bank of America
BAC
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Consumer Discretionary | 6.77% |
| 3 | Healthcare | 6.2% |
| 4 | Financials | 5.48% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4426
State Street SPDR Dow Jones International Real Estate ETF
RWX
$267M
| $47.9K | ﹤0.01% |
1,995
| – | – |
|
|
FONR
4427
DELISTED
Fonar
FONR
| $47.8K | ﹤0.01% |
2,989
-14,759
| -83% | -$242K |
|
4428
InnovAge Holding
INNV
$1.6B
| $47.8K | ﹤0.01% |
9,632
+6,509
| +208% | +$28.3K |
|
|
BLUE
4429
DELISTED
bluebird bio
BLUE
| $47.7K | ﹤0.01% |
2,425
+11
| +0.5% | +$220 |
|
4430
Pure Cycle
PCYO
$259M
| $47.6K | ﹤0.01% |
4,987
+1,394
| +39% | +$13.2K |
|
4431
Akebia Therapeutics
AKBA
$341M
| $47.5K | ﹤0.01% |
46,560
-141,265
| -75% | -$175K |
|
|
LILM
4432
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $47.3K | ﹤0.01% |
+59,520
| New | +$55.8K |
|
|
NAK
4433
Northern Dynasty Minerals
NAK
$812M
| $47.2K | ﹤0.01% |
153,650
| – | – |
|
4434
Cooper-Standard Automotive
CPS
$526M
| $47.2K | ﹤0.01% |
3,791
+741
| +24% | +$10.6K |
|
4435
SkyWater Technology
SKYT
$1.53B
| $47.1K | ﹤0.01% |
6,153
+2,793
| +83% | +$24.2K |
|
|
BRT
4436
BRT Apartments
BRT
$284M
| $47K | ﹤0.01% |
2,691
+504
| +23% | +$8.82K |
|
4437
Timberland Bancorp
TSBK
$348M
| $46.8K | ﹤0.01% |
1,728
+333
| +24% | +$8.47K |
|
4438
Fidelity D&D Bancorp
FDBC
$308M
| $46.7K | ﹤0.01% |
1,067
+70
| +7% | +$3.22K |
|
|
RAPT
4439
DELISTED
RAPT Therapeutics
RAPT
| $46.7K | ﹤0.01% |
1,915
+1,257
| +191% | +$58.1K |
|
4440
NET Power
NPWR
$126M
| $46.7K | ﹤0.01% |
4,747
-44,551
| -90% | -$473K |
|
|
AFCG
4441
AFC Gamma
AFCG
$60.7M
| $46.4K | ﹤0.01% |
5,556
+1,062
| +24% | +$8.74K |
|
4442
Nuveen ESG International Developed Markets Equity ETF
NUDM
$696M
| $46.4K | ﹤0.01% |
+1,489
| New | +$46K |
|
4443
Rimini Street
RMNI
$453M
| $46.2K | ﹤0.01% |
15,062
+3,402
| +29% | +$9.34K |
|
4444
Inovio Pharmaceuticals
INO
$84.7M
| $46.1K | ﹤0.01% |
5,708
-29,472
| -84% | -$310K |
|
|
BLFY
4445
DELISTED
Blue Foundry Bancorp
BLFY
| $46.1K | ﹤0.01% |
5,082
+761
| +18% | +$6.76K |
|
4446
Clarus
CLAR
$128M
| $46.1K | ﹤0.01% |
6,846
+1,224
| +22% | +$8.07K |
|
4447
Bankwell Financial Group
BWFG
$533M
| $46K | ﹤0.01% |
1,813
+363
| +25% | +$8.83K |
|
4448
Korro Bio
KRRO
$151M
| $46K | ﹤0.01% |
1,358
-17,931
| -93% | -$991K |
|
|
SRTA
4449
Strata Critical Medical Inc
SRTA
$440M
| $46K | ﹤0.01% |
13,209
+1,421
| +12% | +$4.74K |
|
4450
Zevra Therapeutics
ZVRA
$575M
| $45.7K | ﹤0.01% |
9,332
+2,279
| +32% | +$10.8K |
|
Similar funds
Citigroup's Q2 2024 Portfolio in Review
As of Q2 2024, Citigroup held 5,888 positions worth $156B, up 2.5% from $152B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citigroup's Q2 2024 filing shows 274 new, 2,819 increased, 1,798 reduced and 330 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M. The largest sale was iShares MSCI EAFE ETF, an estimated $313M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Citigroup's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M.
- Citigroup added most to Intel in Q2 2024, an estimated $436M increase.
- Citigroup's biggest Q2 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $313M.
- Citigroup fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $79.7M.
- Citigroup's ten largest holdings make up 22% of its $156B portfolio in Q2 2024.
- Citigroup opened 274 new positions and closed 330 in Q2 2024.
- Citigroup's portfolio value rose 2.5% quarter-over-quarter to $156B.
Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.